Inovio Pharmaceuticals (INO) Shares Outstanding (2010 - 2026)

Inovio Pharmaceuticals has reported Shares Outstanding (Entity) for 17 years, with the latest figure at $82.3 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 124.33% year-over-year to $82.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $82.3 million (up 124.33% YoY) and the FY2025 annual result came in at $46.9 million, up 72.62% from the prior year.
• Shares Outstanding (Entity) grew to $82.3 million in Q1 2026 per INO's latest filing, from $46.9 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $82.3 million in Q1 2026 and troughed at $18.9 million in Q1 2022.
• A 5-year average of $31.4 million and a median of $25.9 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2023 and 2026: Shares Outstanding (Entity) gained 8.07% in 2023, then jumped 124.33% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $21.1 million in 2022, then grew by 8.07% to $22.8 million in 2023, then increased by 19.16% to $27.2 million in 2024, then surged by 72.62% to $46.9 million in 2025, then jumped by 75.47% to $82.3 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $82.3 million, $46.9 million, and $53.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.